New "True to Life Story" Featuring a Rectal Cancer Survivor is Now Live
May 9, 2025
TOKYO, May 9, 2025 - Olympus Corporation (Olympus) has released the latest installment of its "True to Life Stories," featuring stories of how Olympus is contributing to making people's lives healthier, safer and more fulfilling through advanced medical technologies and solutions. The latest story highlights Kathleen Wiltraut, an employee of Olympus Corporation of the Americas, who was diagnosed with stage 3 rectal cancer at the age of 60.
Rectal cancer develops in the cells of the rectum, the lower part of the large intestine, and is often characterized by symptoms like changes in bowel habits, blood in stool, and unexplained weight loss. "Through this experience, I have become a more positive person," reflects Kathleen, who overcame the difficult treatment and now advocates for early screening. In this True to Life story, she shares her experience and what she learned from it.
Olympus launched the global brand message "True to Life" in December 2021 and has been subsequently implementing various initiatives to raise its brand awareness as a global MedTech company. As part of these initiatives, the company regularly publishes "True to Life Stories" through the form of videos and articles. To view previous stories, click the link below.
https://www.olympus-global.com/company/truetolife/stories/?page=company
About Olympus
At Olympus, we are committed to Our Purpose of making people’s lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide innovative solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit https://www.olympus-global.com/ and follow our global X account: @Olympus_Corp 
.
* Products or devices presented include future technology which may be pending regional regulatory approval and are not available for sale in all regions.
* The contents in this website including products availability, specifications or prices are the information as of the date of announcement and are subject to change without prior notice.
* Information is intended to be presented to the media, shareholders, investors, and other interested parties. Information about our medical products (including products currently under development) included in this website is not intended for advertising or medical advice.
* Olympus Corporation assumes no responsibility for any damage resulting from the use of this material.
* All company names and product names mentioned in this website are trademarks or registered trademarks of their respective companies. ® and TM marks are not specified in this website. All trademarks and registered trademarks are the property of their respective owners.